These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21566656)

  • 1. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.
    Balgobind BV; Zwaan CM; Pieters R; Van den Heuvel-Eibrink MM
    Leukemia; 2011 Aug; 25(8):1239-48. PubMed ID: 21566656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
    Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM
    Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
    Zhang LJ; Lu XL; He J; Li Y
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome.
    Balgobind BV; Zwaan CM; Reinhardt D; Arentsen-Peters TJ; Hollink IH; de Haas V; Kaspers GJ; de Bont ES; Baruchel A; Stary J; Meyer C; Marschalek R; Creutzig U; den Boer ML; Pieters R; van den Heuvel-Eibrink MM
    Leukemia; 2010 Dec; 24(12):2048-55. PubMed ID: 20861917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
    Chen P; Price C; Li Z; Li Y; Cao D; Wiley A; He C; Gurbuxani S; Kunjamma RB; Huang H; Jiang X; Arnovitz S; Xu M; Hong GM; Elkahloun AG; Neilly MB; Wunderlich M; Larson RA; Le Beau MM; Mulloy JC; Liu PP; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11511-6. PubMed ID: 23798388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
    Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
    Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MLL amplification with poor outcome in acute myeloid leukemia.
    Maitta RW; Cannizzaro LA; Ramesh KH
    Cancer Genet Cytogenet; 2009 Jul; 192(1):40-3. PubMed ID: 19480936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11q23/MLL rearrangements in adult acute leukemia.
    Zotova OV; Lukianova AS; Valchuk MO; Karol YS; Shalay OO; Novak VL; Loginsky VE
    Exp Oncol; 2021 Sep; 43(3):229-233. PubMed ID: 34591430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report.
    McGrath M; Smink G
    J Med Case Rep; 2021 May; 15(1):228. PubMed ID: 33957966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL-rearranged leukemias: insights from gene expression profiling.
    Armstrong SA; Golub TR; Korsmeyer SJ
    Semin Hematol; 2003 Oct; 40(4):268-73. PubMed ID: 14582077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on mixed lineage leukemia gene rearrangement in AML-M4/M5 by interphase fluorescence in situ hybridization].
    Pan JL; Xue YQ; Jiang HY; Li JY; Chen SN; Wu YF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):288-90. PubMed ID: 15192841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extramedullary onset of mixed phenotype acute leukemia with MLL gene rearrangement].
    Kawashima I; Shobu Y; Yamamoto T; Hamanaka S; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2013 Mar; 54(3):290-4. PubMed ID: 23676645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
    de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
    Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular findings in childhood leukemia in Brazil: high frequency of MLL-ENL Fusion/t(11;19) in infant leukemia.
    Marques EA; Neves L; Fonseca TC; Lins MM; Pedrosa F; Lucena-Silva N
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):470-4. PubMed ID: 21436736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.
    Coenen EA; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Lo Nigro L; Morimoto A; Perot C; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
    Blood; 2011 Jun; 117(26):7102-11. PubMed ID: 21551233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
    Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
    Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
    Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Shiba N; Ohki K; Hayashi Y; Yamashita Y; Shimada A; Tanaka S; Adachi S
    Haematologica; 2014 Nov; 99(11):e225-7. PubMed ID: 25015941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.